Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Division of Cardiology

Bibliography 2004

2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |

Publications

 Original Articles

  1. Acanfora D, Gheorghiade M, Trojano L, Furfi G, Papa A, Cacciatore F. A randomized, double-blind comparison of lercanidipine 10 and 20 mg in patients with stable effort angina: clinical evaluation of cardiac function by ambulatory ventricular scintigraphic monitoring (VEST). Am J Ther 2004;11:423-432.
  2. Allen LA, O’Donnell CJ, Giugliano RP, Camargo CA, Lloyd-Jones DM. Care concordant with guideline recommendations predicts improved long-term survival in patients with unstable angina/non-ST-elevation myocardial infarction. Am J Cardiol 2004;93:1218-1222.
  3. Amar D, Shi W, Hogue CW, Zhang H, Passman RS, Thomas B, Bach PB, Damiano R, Thaler HT. Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol  2004;44:1248-1253.
  4. Arora R, Krummerman A, Vijayaraman P, Rosengarten M, Suryadevara V, Lejemtel T, Ferrick KJ. Heart rate variability and diastolic heart failure.  Pacing Clin Electrophysiol 2004;27:299-303.
  5. Benjamin JM, Torke SJ, Demeler B, and McGarry TJ.  Geminin has dimerization, Cdt1-binding, and destruction domains that are required for biological activity. J Biol Chem 2004;279:45957-45968.
  6. Benza RL, Tallaj JA, Felker MG, Zabel MK, Kao W, Bourge RC, Pearce D, Leimberger JD, Borzak S, O’Connor CM, Gheorghiade M. The impact of arrythmias in hospitalized patients with acute decompensated heart failure. J Card Fail 2004;10:279-284.
  7. Beohar N, Flaherty JD, Davidson CJ, Maynard RC, Robbins JD, Shah A, Choi JW, MacDonald LA, Jorgensen JP, Pinto JV, Klaus HM, Wang N, Harris KR, Decker R, Bonow RO. The antirestenotic effects of a locally delivered caspase inhibitor attenuating apoptosis in a balloon injury model. Circulation 2004;109:108-113
  8. Bairey Merz N, Bonow RO, Sopko G, Balaban RS, Cannon RO, III, Gordon D, Hand MM, Hayes SN, Lewis JF, Long T, Manolio TA, MD, Maseri A, Nabel EG, Desvigne Nickens P, Pepine CJ, Redberg RF, Rossouw JE, Selker HP, Shaw LJ, Waters, DD. Women’s Ischemic Syndrome Evaluation: Current status and future research directions. Report of the National Heart, Lung, and Blood Institute Workshop October 2-4,2003: Executive Summary. Circulation 2004:109:805-807 
  9. Berger JA, Sanborn TA, Sherman W, Brown DL. Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention. Am J Cardiol 2004;94:647-649.
  10. Berger JA, Sanborn TA, Sherman W, Brown DL. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol 2004;94:649-651
  11. Bonow RO. Update in Cardiology. Ann Intern Med 2004;141:628-634.
  12. Bonow RO. Prevention of cardiovascular disease: challenges and opportunities. Ital J Cardiol 2004;5:6S-8S.
  13. Bonow RO, Smith SC Jr. Cardiovascular manpower: the looming crisis. Circulation 2004;109:817-820.
  14. Bonow RO, Gheorghiade M. The diabetes epidemic: a national and global crisis. Am J Med 2004;116(5A):2S-10.
  15. Bonow RO. Prevention of cardiovascular disease: challenges and opportunities. Ital J Cardiol 2004;5:6S-8S.
  16. Bonow RO, Zipes DP (co-chairs), Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Faxon D, Lima JAC, Roberson RM. ACCF/AHA Consensus Conference Report on Professionalism and Ethics. Task Force 5: Expert testimony and opinions. Circulation 2004;2535-2537 and J Am Coll Cardiol 2004;44:1747-1749
  17. Borello F, Beahan M, Klein L, Gheorghiade M. Reappraisal of ß-blocker therapy in the acute and chronic post-myocardial infarction period. Am J Cardiol 2004;93:21B-29B.
  18. Choi JW, Gibson CM, Murphy SA, Davidson CJ, Kim RJ, Ricciardi MJ. Myonecrosis following stent placement: association between impaired TIMI myocardial perfusion grade (TMPG) and MRI visualization of microinfarction. Catheter Cardiovasc Intervent 2004;61:472-476
  19. Coussios CC, Holland CK, Jakubowska L, Huang SL, MacDonald RC, Nagaraj A, McPherson DD.  In vitro characterization of liposomes and Optison® by acoustic scattering at 3.5 MHz. Ultrasound Med Biol 2004;30:181-190.
  20. Crowley W Jr, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johson SB, Dobs A, Genel M, Korn A, Reame N, Bonow RO, Grebb J, Rimoin D. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish the National Clinical Research Enterprise. JAMA 2004;291:1120-1126
  21. Danciu SC, Klein L, Mir Hosseini M, Ibrahim L, Coyle BW, Kehoe RF. A predictive model for survival after in hospital cardiopulmonary arrest. Resuscitation 2004;62:35-42.
  22. Daviglus ML, Liu K, Yan LL, Pirzada A, Manheim L, Manning W, Garside DB, Wang R, Dyer AR, Greenland P, Stamler J. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. JAMA 2004;292:2743-2749.
  23. Daviglus ML Pirzada A, Liu K, Yan LY, Garside DB, Dyer AR, Hoff JA, Kondos GT, Stamler J, Greenland P.  Comparison of low risk and higher risk profile in middle age to frequency and quantity of coronary artery calcium years later. Am J Cardiol 2004;94:367-369.
  24. Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, Wang R, Dyer AR, Lloyd-Jones DM, Greenland P. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 2004; 292:1588 - 1592.
  25. De Luca L, Gheorghiade M.  Hospitalizations for worsening chronic heart failure. Ital J Cardiol 2004;5:55S-62S.
  26. Devaraj S, Rosenson RS, Jialal I.  Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am 2004;33:431-453.
  27. Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare GF. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation 2004;110:2721-2746.
  28. Driscoll SD, Meininger G, Lareau M, Dolan SE, Killilea KM, Hadigan C, Lloyd-Jones DM, Klibanski A, Frontera WR, Grinspoon S. Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS 2004;18:465-473.
  29. Dyer AR, Greenland P, Elliott P, Claeys G, Kesteloot H, Ushima H, Stamler J: INTERMAP Research Group.  Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 2004;160:1122-1131.
  30. Dyer AR, Greenland P, Elliott P, Daviglus M, Claeys G, Stamler J, for the INTERMAP Research Group. Estimating laboratory precision of urinary albumin excretion and other urinary measures in the INTERMAP Study of Macronutrients and Blood Pressure. Am J Epidemiol 2004;160:1122-1131.
  31. Dyer AR, Stamler J, Garside DB, Greenland P. Long-term consequences of body mass index for cardiovascular mortality:  The Chicago Heart Association Detection Project in Industry Study.  Ann Epidemiol 2004;14:101-108.
  32. Eimer MJ, Ekery D, Rigolin VH, Bonow RO, Cotts W. Elevated B-type natriuretic peptide (BNP) in asymptomatic patients with chronic aortic regurgitation and preserved left ventricular systolic function Am J Cardiol 2004;94:676-678
  33. Eimer, M, Stone NJ. Evidence based treatment of dyslipdemia in adults. Curr Atherosclerosis Rep 2004;6:388-397.
  34. Endres A, Mayuga K, Cristofaro A, Hoberman M, Goldberger J, Kadish A.  Menstrual cycle and ST height.  Ann Noninvasive Electrocardiol 2004;9:121-126.
  35. Fann JI, St Goar FG, Komtebedde J, Oz MC, Block PC, Foster E, Butany J, Feldman T, Burdon TA: Beating heart catheter-based-edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation 2004;110:988-993.
  36. Faxon DF, Schwamm LH, Pasternak RC, Peterson ED, McNeil BJ, Bufalino V, MD; Yancy CW, Brass LM, Baker DW, Bonow RO, Smaha LA, Jones D, Smith SC Jr, Ellrodt G, Allen J, Schwartz S, Fonarow G, Duncan P, Horton K, Smith R, Stranne S, Shine K.  Improving quality of care through disease management: principles and recommendations from the American Heart Association’s Expert Panel on Disease Management.  Circulation 2004;109:2651-2654 and Stroke 2004;35:1527-30
  37. Feldman T. Intra-Procedure Guidance for Percutaneous Mitral Valve Interventions: TTE, TEE, ICE or Xray? Cathet Cardiovasc Intervent 2004;63:395-396.
  38. Felker MG, Leimberger JD, Califf RM, Cuffe MS, Gheorghiade M, O’Connor CM. Risk stratification after hospitalization for decompensated heart failure. J Card Fail 2004;10:460-466.
  39. Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS, Parker MA, Klocke FJ, Kim RJ, Judd RM.  Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size.  J Am Coll Cardiol 2004;43:2124-2131.
  40. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Connor CM, Yancy CW, Young J. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 2004;148:43-51
  41. Fonarow GC, Gheorghiade M, Abraham WT. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.  Am J Cardiol. 2004 1;94:1155-1160.
  42. Fox CS, Parise H, D’Agostino RB, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. Parental history is a risk factor for atrial fibrillation: The Framingham Heart Study. JAMA 2004;291:2851-2855.
  43. Franklin BA, Kahn JK, Gordon NF, Bonow RO. A cardioprotective "polypill"? Independent and additive benefits of lifestyle modification. Am J Cardiol 2004;94:162-166
  44. Gami AS, Holly TA, Rosenthal JE. Electrocardiographic poor R-wave progression: analysis of multiple criteria reveals little usefulness. Am Heart J  2004;148:80-85.
  45. Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 2004;43:1534-1541.
  46. Gattis WA, O'Connor CM, Hasselblad V, Adams KF Jr, Kobrin I, Gheorghiade M. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 Trial). Am J Cardiol. 2004;93:1436-1437.
  47. Gheorghiade M, Adams KF Jr, Colucci WS. Digoxin in the management of cardiovascular disorders. Circulation. 2004;109:2959-2964.
  48. Gheorghiade M, Gattis WA, O'Connor CM, Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew FA, Klapholz M, Ouyang J, Orlandi C; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 2004;291:1963-1971
  49. Gheorghiade M, Klein L, Stone NJ, Bonow RO, Kim RJ. Improvement in the function of hibernating myocardium in a patient with heart failure due to coronary artery disease receiving high-dose simvastatin. Ital J Cardiol 2004;5:160-162
  50. Gheorghiade M, Robbins JD, Lukas MA. Role of carvedilol in atrial fibrillation: insights from clinical trials. Am J Cardiol 2004;93:53B-7B.
  51. Greenland P. A new editorial team for Archives of Internal Medicine: the choices we make.
    Arch Intern Med 2004;164:1480-1481.
  52. Greenland P.  Maintaining impartial judgment at the Archives of Internal Medicine.  Arch Intern Med 2004;164:2304.
  53. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC.  Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-215.
  54. Hamilton AJ, Huang SL, Warnick D, Rabbat M, Kane B, Nagaraj A, Klegerman M, McPherson DD.  Intravascular ultrasound molecular imaging of atheroma components in vivo.  J Am Coll Cardiol 2004;43:453-460.
  55. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004;109:2705-2711.
  56. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P.  Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 2004;35:1538-1542.
  57. Kadish AH.  Can radiofrequency ablation get on your nerves? Heart Rhythm 2004;1:6;718-719.
  58. Kadish AH. What is a monophasic action potential?  Cardiovasc Res 2004;63:580-581.
  59. Kadish AH. Implantable cardioverter defibrillator therapy for ambulatory ventricular tachycardia: are we using an elephant gun? J Cardiovasc Electrophysiol 2004;15:1-2.
  60. Kadish, AH. Prophylactic ICD implantation in nonischemic dilated cardiomyopathy: Evidence-Based Medicine.  Medscape.com 2004. (Accessed June 24, 2004, at http://www.medscape.com/viewprogram/3192_pnt)
  61. Kadish AH, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158.
  62. Kadish AH, Greenland P, Limacher MC, Frishman WH, Daugherty SA, Schwartz JB.  Estrogen and progestin use and the QT interval in postmenopausal women.  Ann Noninvasive Electrocardiol 2004;9:366-374.
  63. Kannankeril P, Le F, Kadish A, Goldberger J: Parasympathetic effects on heart rate recovery after exercise.  J Invest Med 2004;52:394-401.
  64. Kim CX, Davidson CJ.  Primary coronary intervention in acute myocardial infarction. Ital Heart J 2004;5:76S-82S
  65. Klein L, Gattis WA, Borrello F, Wu E, O'Connor CM, Gheorghiade M. Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging study. Am J Cardiol 2004;93:44A-46A.
  66. Klein L, Galvez A, Klein O, Chediak J. Warfarin - induced limb gangrene in the setting of lung adenocarcinoma. Am J Hematol 2004;76:175-178.
  67. Klein L, Gheorghiade M. Management of the patient with diabetes mellitus and myocardial infarction: clinical trials update. Am J Med 2004;116(5A):47S-63S.
  68. Klein L, Gheorghiade M. Coronary artery disease and prevention of heart failure. Med Clin North Am 2004;88:1209-1235.
  69. Klocke FJ.  Cardiac MRI: what can it add clinically in 2004? J Am Heart Hospital 2004;2:97-99.
  70. Kumar A, Anel R, Bunnell E, Habet K, Neumann A, Wolff D, Rosenson R, Cheang M, Parrillo J.  Effect of large volume infusion on left ventricular volumes, performance and contractility parameters in normal volunteers. Intensive Care Med 2004;30:1361-1369.
  71. Ledesma M, Martínez P, Cázares MA, Feldman T. Transcatheter treatment of Lutembacher Syndrome: combined balloon mitral valvuloplasty and percutaneous ASD closure. J Invasive Cardiol 2004;16:678-679.
  72. Lee DC, Simonetti OP, Harris KR, Holly TA, Judd RM, Wu E, Klocke FJ. Magnetic resonance vs. radionuclide pharmacologic stress perfusion imaging for flow-limiting stenoses of varying severity.  Circulation 2004;110:58-65.
  73. Liu Y, Hamilton A, Nagaraj A, Yan LL, Liu K, Lai YG, McPherson DD, Chandran KB. Alterations in fluid mechanics in porcine femoral arteries with atheroma development. Ann Biomed Engineering 2004;32:544-554.
  74. Lloyd-Jones DM, Greenland P. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? (letter). Circulation 2004;110:e532.
  75. Lloyd-Jones DM, Nam BH, D’Agostino RB, Levy D, Murabito JM, Wang TJ, Wilson PWF, O’Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004;291:2204-2211.
  76. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for developing atrial fibrillation: the Framingham Heart Study. Circulation  2004;110:1042-1046.
  77. Lloyd-Jones DM, Wilson PWF, Larson MG, Beiser A, Leip EP, D’Agostino RB, Levy D. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004;94:20-24.
  78. Loscalzo J, Bonow RO, Jacobs AK. Coronary calcium screening and the American Heart Association news embargo. Circulation 2004;110:3504-3505
  79. Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle:  a call to action for clinicians.  Arch Intern Med 2004;164:249-258.
  80. Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. Blood pressure and risk of secondary cardiovascular events in women:  The women's antioxidant cardiovascular study (WACS). Circulation 2004;109:1623-1629.
  81. McDermott MM, Criqui MH, Greenland P, Guralnik JM, Liu K, Pearce WH, Taylor L, Chan C, Celic L, Woolley C, O'Brien MP, Schneider JR.  Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance. J Vasc Surg 2004;39:523-530.
  82. McDermott MM, Greenland P, Guralnik JM, Ferrucci L, Green D, Liu K, Criqui MH, Schneider FR, Chan C, Ridker P, Pearce WH, Martin G, Clark E, Taylor L.  Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease.  Vasc Med 2004;9:107-115.
  83. McDermott MM, Greenland P, Hahn E, Hirsch A, Pearce WH, Cella D, Ockene JK, Brogan D, Criqui MH, Lipsky M, Odom L, Hanley K, Kahn S.  The effects of continuing medical education credits on physician response rates to a mailed questionnaire.  Health Mark Q  2004;20:27-42.
  84. McDermott MM, Guralnik JM, Greenland P, Green D, Liu K, Ridker PM, Chan C, Criqui MH, Ferrucci L, Taylor LM, Pearce WH, Schneider JR, Oskin SI. Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2004;52:1888-94.
  85. McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292:453-461.
  86. McDermott MM, Tiukinhoy S, Greenland P, Liu K, Pearce WH, Guralnik JM, Unterreiner S, Gluckman T, Criqui MH, Ferrucci L.  A pilot exercise intervention to improve lower extremity functioning in peripheral arterial disease unaccompanied by intermittent claudication.  J Cardiopulm Rehabil 2004;24:187-196.
  87. McGarry TJ. Measurement of geminin activity in xenopus egg extracts. Methods Mol Biol 2004;296:263-278.
  88. Mehra MR, Gheorghiade M, Bonow RO. Mitral regurgitation in chronic heart failure: more questions than answers? Curr Cardiol Rep 2004;6:96-99
  89. Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H. Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western Electric Study. Am J Epidemiol 2004;159:572-580.
  90. Murabito JM, Nam BH, D’Agostino RB, Lloyd-Jones DM, O’Donnell CJ, Wilson PWF. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004;140:434-440.
  91. Mutharasan RK, Nagaraj A, Hamilton AJ, McPherson DD, Bharati S.  Computer three-dimensional reconstruction of the atrioventricular conduction system.  Pacing Clin Electrophysiol  2004;27:740-748.
  92. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger JJ. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol 2004;44:1883-1888.
  93. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, LeWinter M, Porte D, Semenkovich CF, Smith SC Jr, Young LH, Kahn R. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 2004;27:256-263.
  94. Ng J, Sahakian AV, Fisher WG, Swiryn S. Surface ECG vector characteristics of organized and disorganized atrial activity during atrial fibrillation. J Electrocardiol 2004;37 Suppl:91-97.
  95. Nishio M, Ruch S, Kelly JE, Aistrup GA, Sheehan K, Wasserstrom JA: Ouabain increases sarcoplasmic reticulum calcium release in cardiac myocytes. J Pharmacol Exp Ther 2004;308:1181-1190.
  96. Olin JW, Kaufman JA, Bluemke DA, Bonow RO, Gerhard MD, Jaff MR, Lederman RJ, Rubin GD. American Heart Association Conference on Atherosclerotic Vascular Disease. Writing group IV: Imaging. Circulation 2004;109:2626-2633.
  97. Passman R, Kadish A, Dibs S, Engelstein E, Goldberger J.  Radiofrequency ablation of atrial flutter: a randomized controlled trial of two anatomic approaches.  Pacing Clin Electrophysiol  2004;27:83-88.
  98. Passman R, Horvath G, Thomas J, Kruse J, Shah A, Goldberger J, Kadish A; Clinical spectrum and prevalence of neurologic events provoked by tilt table testing. Arch Intern Med 2003;163:1945-1948.
  99. Passman R, Weinberg K, Freher M, Schaechter A, Goldberger J, Kadish. Accuracy of mode switch algorithms for the detection of atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2004;15:773-777.
  100. Pepine CJ, Balaban RS, Bonow RO, Diamond GA, Johnson BD, Johnson PA, Mosca L, Nissen SE, Pohost GM. Women’s Ischemic Syndrome Evaluation: Current status and future research directions. Report of the National Heart, Lung, and Blood Institute Workshop October 2-4,2003:  Section 1. Diagnosis of stable ischemia and ischemic heart disease. Circulation 2004;109:e44-46
  101. Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes. Am J Med 2004; 116(5A):64S-75S
  102. Racker, DK. The AV junction region of the heart: a comprehensive study correlating gross anatomy and direct three-dimensional analysis. Part II. Morphology and cytoarchitecture. Am J Physiol Heart Circ Physiol 2004:286:H1853-H1871.
  103. Raghavan ML, Trivedi S, Nagaraj A, McPherson DD, Chandran KB.  Three-dimensional finite element analysis of residual stress in arteries. Ann Biomed Eng 2004;32:257-263.
  104. Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Marrya FT. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Clin Ther 2004;26:1400-10.
  105. Rosenson RS.  Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 2004;173:1-12.
  106. Rosenson RS.  Current overview of statin-induced myopathy. Am J Med 2004;116:408-416.
  107. Rosenson RS.  Clinical role of LDL and HDL subclasses and apolipoprotein measurement. ACC Curr J Rev 2004;13:33-37.
  108. Rosenson RS. LDL cholesterol lowering with statins:  how reliably can clinical events be predicted?  Evidence-Based Healthcare 2004;8:48-49.
  109. Rosenson RS.  Inflammation and the vulnerable patients. Lipid Letter 2004;3:6-7.
  110. Rosenson RS. Statins: can the new generation make an impression? Expert Opin Emerg Drugs.2004;9:269-279.
  111. Rosenson RS, Reasner C.  Therapeutic approaches in the prevention and treatment of cardiovascular disease in metabolic syndrome and type 2 diabetes patients. Curr Opin Cardiol 2004;19:480-487.
  112. Rosenson RS, Tagney CC, Levine DM, Parker TS, Gordon BR. Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia. Atherosclerosis 2004;177:77-81.
  113. Rosenson RS, Wolff D. Comparison of two whole blood viscometers: implications for cardiovascular and thrombosis research. Thromb Haemost 2004;92:225-226.
  114. Rosenson RS, Wolff D, Green D, Boss AH, Kensey KR.  Aspirin does not alter blood viscosity. J Thromb Hemost 2004;2:340-341.
  115. Rosenson RS, Wolff D, Tangney CC.  Statins reduce oxidized LDL levels but do not alter soluble ICAM-1 and VCAM-1 levels in hypercholesterolemia subjects. Clin Sci (Lond) 2004; 106:215-217.
  116. Rucker-Whitaker C, Greenland P, Liu K, Chan C, Guralnik JM, Criqui MH, Taylor LM, Pearce WH, McGrae-McDermott M.  Peripheral arterial disease in African-Americans: clinical characteristics, leg symptoms, and lower extremity functioning.  J Am Geriatr Soc 2004;52:922-930.
  117. Sanborn TA, Feldman T. Management strategies for cardiogenic shock. Curr Opin Cardiol 2004;19:608-612.
  118. Sanborn TA, Jacobs AK, Frederick PD, Every NR, French WJ; National Registry of Myocardial Infarction 3 and 4 Investigators. Comparability of quality-of-care indicators for emergency coronary angioplasty in patients with acute myocardial infarction regardless of on-site cardiac surgery (report from the National Registry of Myocardial Infarction). Am J Cardiol 2004;93:1335-1339.
  119. Sanborn TA, Ogilby JD, Ritter JM, Stone GW, Klugherz BD, Fields RH, White CC, Wilensky RL. Reduced vascular complications after percutaneous coronary interventions with a nonmechanical suture device: results from the randomized RACE study. Catheter Cardiovasc Interv 2004;61:327-332.
  120. Seghatol FF, Shah DJ, DiLuzio S, Bello D, Johnson MR, Cotts WG, O’Donohue JA, Bonow RO, Gheorghiade M, Rigolin VH. Relation between contractile reserve and improvement in left ventricular function with beta blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:854-859
  121. Sibley C, McGann, S. Stone NJ. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia. Am J Cardiol 2004;94:699-700.
  122. Smith, SC Jr, Anderson JL, Cannon RO, Yazid F, Koenig W, Libby P, Lipschultz S, Mensah G, Ridker PM, Rosenson RS.  CDC/AHA workshop on inflammatory markers and cardiovascular disease: application to clinical and public health practice: report of the clinical practice group.  Circulation 2004;110:e550-553.
  123. Smith, SC Jr, Milani RV, Arnett DK, Crouse, III, JR, McGrae McDermott M, Ridker PM, Rosenson RS, Taubert KA, Wilson, W.F., P.  American Heart Association Conference on Atherosclerotic Vascular Disease. writing group II: Risk factors. Circulation 2004; 109:2613-2626.
  124. Stone P, Lloyd-Jones DM, Johnstone M, Carlson W, Rubenstein J, Andrews T, Creager M, Frei B, Orav J, Sopko G, Clark M, MacCallum G, Selwyn A. The Vascular Basis for the Treatment of Myocardial Ischemia Study: trial design and baseline characteristics. Am Heart J 2004;147:875-882.
  125. Stroe AF, Gheorghiade M. Carvedilol: beta-blockade and beyond. Rev Cardiovasc Med 2004;5:S18-27.
  126. Sundaram S, Goldberger J: Risk stratification and epidemiology of sudden death.  Curr Cardiol Rep 2004;6:333-338.
  127. Syed, Z, Salinger MH, Feldman T: Alterations in left atrial pressure and compliance during balloon mitral valvuloplasty. Cathet Cardiovasc Intervent 2004;61:571-579.
  128. Syed IS, Sanborn TA, Rosengart TK. Therapeutic angiogenesis: a biologic bypass. Cardiology 2004;101:131-43.
  129. Taneja T, Horvath G, Racker DK, Johnson D, Goldberger J, Kadish A. Is there a correlation between ventricular fibrillation cycle length and electrophysiologic and anatomic properties of the canine left ventricle? Am J Physiol Heart Circ Physiol 2004: 287:H823-H832.
  130. Thattassery E, Gheorghiade M. Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction. Heart Fail Rev 2004;9:107-113.
  131. Tiukinhoy S, Khan A, Huang S, Klegerman M, MacDonald R, McPherson D.  Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol 2004;39:104-110.
  132. Udelson JE, Dilsizian V, Bonow RO. The historical and conceptual evolution of radionuclide assessment of myocardial viability. J Nucl Cardiol 2004;11:318-334
  133. Wagh A, Stone NJ. Treatment of metabolic syndrome. Expert Rev Cardiovasc Ther 2004;2:213-228.
  134. Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 2004;292:2849-2859.
  135. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera G, Greenland P, Cochrane B, Robbins R, Aragakib A, Dunbar-Jacob J.  Depression and cardiovascular sequelae in post-menopausal women. Arch Intern Med 2004;164:289-298. 
  136. Wilson SR, Vakili BA, Sherman W, Sanborn TA, Brown DL. Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care 2004;27:1137-1142.
  137. Yan LL, Daviglus ML, Liu K, Pirzada A, Garside DB, Schiffer L, Dyer AR, Greenland P.  Body mass index and health-related quality of life in adults 65 years and older.  Obesity Res 2004;12:69-76.
  138. Zakarija A, Bandarenko N, Pandey D, Auerbach A, Raisch D, Kim B, Kwaan H, McKoy J, Schmitt B, Davidson CJ, Yarnold PR, Gorelick P, Bennett C.  Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.  Stroke 2004;35:533-537.
     
  139. Zamorano J, Perez de Isla L, Suggenf L, Cordeiro P, Rodrigo JL, Almeria C, Weinert L, Feldman T, Macaya C, Lang RM. Non-invasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real time 3D echocardiography.  Eur Heart J 2004;25:2086-2091.


Books, Symposia

  1. Brinker JA, Davidson CJ, Laskey W, eds.  Preventing in-hospital cardiac and renal complications in high-risk PCI patients.  Center for Bio-Medical Communications, Inc., 2004.
  2. Gheorghiade M, Bonow RO. Optimal Care of the Patient With Diabetes Across the Cardiovascular Disease Spectrum. Am J Med 2004:116(5A):1S-90S.
  3. Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition.  Philadelphia: Elsiever Science 2004.

Book Chapters

  1. Beohar N, Ricciardi MJ, Davidson CJ. Cardiac Catheterization. In: Rosendorff C, ed. Essential Cardiology. Philadelphia: WB Saunders. (in press).
  2. Bonow RO, Braunwald E. Valvular heart disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia: Elsiever Science 2004, pp 1553-1621.
  3. Brook RD, Greenland P.  Secondary prevention.  In:  Preventive Cardiology.  3rd Edition.  New York:  McGraw-Hill  2004, pp 515-542. 
  4. Davidson CJ, Bonow RO. Cardiac catheterization. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia: Elsiever Science 2004; pp 395-422.
  5. Emanuel LL, Bonow RO. Care of patients with end-stage heart disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia: Elsiever Science 2004, pp 53-61.
  6. Feldman T, Salinger M:  Inoue balloon mitral commissurotomy and aortic valvuloplasty. In: Kern MJ, ed. Interventional Cardiac Catheterization Handbook. 2nd edition. Mosby-Year Book 2004, pp 441-480.
  7. Feldman T, Sandborn T, Ziskind AA, Kern MJ. Pericardiocentesis, balloon pericardiotomy and special techniques. In: Kern MJ, ed. Interventional Cardiac Catheterization Handbook. 2nd edition. Mosby-Year Book 2004, pp 481-499.
  8. Feldman T, Sanborn TA, O’Neill WW: Balloon aortic and pulmonic valvuloplasty. In: Herrmann HC, ed. Contemporary Cardiology: Interventional Cardiology-Percutaneous Noncoronary Intervention. Humana Press 2004, pp 29-48.
  9. Goldberger J, Weinberg KM, Kadish AH.  Impact of nontraditional antiarrhythmic drugs on sudden cardiac death.  In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology From Cell to Bedside. 4th edition. Philadelphia: Elsevier Science 2004, pp 950-958.
  10. Holly TA, Bonow RO. Assessment of myocardial viability with thallium-201 and technetium-based agents. In: Zaret BL and Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd edition. Philadelphia: Elsevier Science 2004, pp 503-518.
  11. Kern MJ, Feldman T, Bitar S: Hemodynamic data. In: Kern MJ, ed. The Cardiac Catheterization Handbook. 4th edition. Mosby-Year Book 2003, pp 126-216.
  12. Lloyd-Jones DM and O’Donnell CJ. Hypertension as a risk factor for stroke: Epidemiology of blood pressure risks and evidence for treatment benefit. In: Furie KL, Kelly PJ, eds.  Handbook of Stroke Prevention in Clinical Practice. Totowa, NJ: Humana Press 2004, pp 35-50.
  13. Miller JM, Das M, Arora R, Alberta-Lista C, Wu J. Differential diagnosis of wide QRS complex tachycardia. In Zipes DP, Jalife J, eds. Cardiac Electrophysiology:From Cell to Bedside. 4th edition. Philadelphia: Elsevier Science (in press).
  14. Passman R, Kadish A. When to refer atrial fibrillation patients for pulmonary vein isolation. Harrison’s Online, 2004.
  15. Sivaratnam DA, Bonow RO, Kalff V. Assessment of myocardial viability in dysfunctional myocardium. In: Murray IPC and Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. 3rd edition. Edinburgh: Churchill Livingstone 2004, pp1159-1170.
  16. St. Goar FG, Fann JI, Feldman TE, Block PC, Herrmann HC: Percutaneous mitral valve repair with the edge-to-edge technique. In: Herrman HC, ed. Contemporary Cardiology: Interventional Cardiology-Percutaneous Noncoronary Intervention. Humana Press, 2004, pp 87-95.
  17. Stone NJ. Focus on lifestyle change and the metabolic syndrome. In Grundy S, ed. Metabolic Syndrome, Endocrinology Clinics of North America. Elsevier/Saunders (in press).
  18. Stone, N. Treatment of dyslipidemia. In Atlas of Atherosclerosis. 4th Edition. (in press).
  19. Syed IS, Sanborn TA, Rosengart TK. Angiogenesis clinical trials. In: Kimchi A, ed. Heart Disease, Pathogenesis, Diagnosis and Treatment. Bologna, Italy: Medimond 2004, pp. 271-282.
  20. Udelson JE, Dilsizian V, Bonow RO. Nuclear cardiology. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine. 7th edition. Philadelphia: Elsiever Science 2004, pp 287-331.


Abstracts

  1. Adams KF Jr, Patterson JH, Gattis W, O'Connor CM, Lee CR, Schwartz TA, Gheorghiade M. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group (DIG) trial: a retrospective analysis. Eur Heart J. 2004;25:P278.
  2. Adams KF, Patterson JH, Gattis WA, O'Connor CM, Lee CR, Schwartz TA, Gheorghiade M. Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group (DIG) Trial: a retrospective analysis. J Card Fail 2004;10:S23.
  3. Alla FM, Patterson JH, Gattis WA, O'Connor CM, Lee CR, Schwartz TA, Gheorghiade M, Adams KF Jr.  Women with preserved systolic function have better survival than men: retrospective analysis of the Digitalis Investigational Group (DIG) Trial. J Card Fail 2004;10:S90.
  4. Allie DE, Caputo R, Ansel G, Fail PS, Khan MH, on behalf of the pivotal Angiolink trial Investigators. Angiolink EVS arteriotomy staple mediated closure device: safety and effectiveness in patients with peripheral vascular disease, a subset analysis of the pivotal Angiolink Trial. Am J Cardiol 2004;94:58E.
  5. Amar D, Zhang H, Hogue CW Jr, Shi W, Passman R, Bach P, Thaler HT. Preoperative risk factors for post-CABG atrial fibrillation.  J Am Coll  Cardiol  2004;43:272A
  6. Ansel G, Sharma R, Fail P, Khan MA, Keller VA, Stoler R, Nielsen C, Sanborn TA, Hall P, Hammett C. A pivotal, prospective multicenter, open-label, randomized study to determine the safety and effectiveness of the EVS vascular closure system. Am J Cardio, 2004;94:124E.
  7. Beohar N, Brodsky A, Davidson CJ, Lee D, Wu E, Bolson E, Bonow RO, Sheehan F. The centersurface method for quantitative evaluation of cardiac magnetic resonance regional wall thickening. J Am Coll Cardiol 2004;43:207A.
  8. Beohar N, Flaherty JD, Davidson CJ, Brodsky A, Lee D, Wu E, Bolson E, Bonow RO, Sheehan F.  The CenterSurface Method for three dimenstional reconstruction of cardiac MR images to quantitatively evaluate regional wall thickening and global left ventricular function. Am J Cardiol 2004;94:162E.
  9. Berger JS, Sanborn TA, Sherman W,  Brown DL. The impact of renal insufficiency on long-term survival of patients with diabetes undergoing percutaneous coronary intervention. J Am Coll Cardiol 2004;43:47A.
  10. Berger JS, Sherman W, Sanborn TA, Brown DL. Systolic heart failure is associated with a significantly worse long-term survival than diastolic heart failure among patients with coronary artery disease. J Am Coll Cardiol 2004;43:179A.
  11. Berkowitz MJ, Harkness S, Hochman J, Picard M, Sanborn TA, Keller N, Slater J. Echocardiographic and angiographic correlations in cardiogenic shock. J Am Coll Cardiol 2004;43:173A.
  12. Butler J, Miller A, Oren RM, Ghali JK, Pavlovic-Surjancev B, Sueta CA, O'Connor CM, Hebert K, Gheorghiade M, Schocken D, Cotts W, Schwartz TA, Adams KF, Jr., The STAMINA-HFP Investigators. Contemporary dosing of angiotensin converting enzyme inhibitors and beta blockers in chronic heart failure: report from the STAMINA:HFP (Study of Anemia in a Heart Failure Population) Registry. J Am Coll Cardiol 2004;43:158A.
  13. Choi JW, MacDonald LA, Smith AM, Klein LW, Linsky N, Ricciardi MJ. Sex proportion of offspring and exposure to radiation in male invasive/interventional cardiologists (SPERMI). Catheter Cardiovasc Intervent 2004;62:101-102.
  14. Danciu SC, Klein L. Anemia is frequent and associated with an increased length of stay in patients hospitalized with worsening heart failure and diastolic dysfunction. J Card Fail. 2004;10:S95.
  15. Davidson CJ, Nebeker J, Klinge S, Bennett, CL, Feldman MD.  Report on 141 hypersensitivity cases associated with the CYPHER sirolimus eluting cardiac stent. Circulation 2004;110:III-527.
  16. Daviglus ML, Liu K, He K, Yan LL, Klein L, Schreiner PJ, Lewis CE, Siscovick DS, Wang R, Van Horn L. Dietary calcium in young adulthood and subclinical coronary atherosclerosis in middle age: the CARDIA study. Circulation. 2004;110:III-797.
  17. Eimer MJ, Rossi JS, Subacius H, Kulik L, Abecassis M, Flamm S, Beahan M, Bonow RO, Gheorghiade M. Unexplained severe systolic heart failure following liver transplantation. Circulation 2004;110:III-605
  18. Elkayam U, Tasissa G, Binanay C, Wagoner L, Gheorghiade M, Warnica JW, Young J, Rayburn BK, Rogers J, De Marco T, Leier CV. Use and impact of inotropes and vasodilator therapy during heart failure hospitalization in the ESCAPE Trial. Circulation. 2004;110:III-515.
  19. Feldman T, Herrmann HC, Block PC, Whitlow PL, St. Goar F, Foster E. Late Breaking Clinical Trials: Percutaneous Mitral valve repair using the edge-to-edge technique: phase 1 US trial results.  J Am Coll Cardiol 2004;94:S79.
  20. Feldman T, Herrmann HC, Wasserman HS, Whitlow PL, Block PC, Gray WA, Foster E, St. Goar F: Percutaneous edge-to-edge mitral valve repair using the Evalve clip: current status of the EVEREST phase I clinical trial. Am J Cardiol 2004;94:79E.
  21. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O’Conner CM, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators. The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure: rtionale, design, and implementation. Circulation. 2004;109:e50.
  22. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young JB, OPTIMIZE HF Investigators and Coordinators. Initial hospital, patient, and performance measure characteristics of the Organized Program To Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Program. J Card Fail. 2004;10:S112.
  23. Ghali JK, Oren RM, Dunlap SH, Wagoner LE, Pina IL, Miller AB, O'Connor CM, Gheorghiade M, Sueta CA, Hebert K, Chabert LJ, Hunter JJ, Schocken DD, Schwartz TA, Adams KF Jr for STAMINA-HFP Investigators. Lower hemoglobin is associated with persistently reduced quality of life in unselected patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Circulation.  2004;110:III-476.
  24. Gheorghiade M, Krum H, Chu TC, Patni R, Pitt B. Concurrent treatment with eplerenone and standard HF therapy reduces the duration of heart failure hospitalization in patients with post acute myocardial infarction heart failure. Circulation. 2004;110:III-519.
  25. Gheorghiade M, O'Connor CM, Adams KF, Hollenberg NK, Udelson JE, Zimmer CA, Ouyang J, Orlandi C. Prognostic value of elevated BUN in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF). Circulation. 2004;110:III-749.
  26. Gordon D, Taneja T, Koolish D, Johnson D, Ulphani, JS, Goldberger J, Kadish A.  Regional distribution of depolarization alternans preceding ventricular fibrillation onset in a canine ischemic model.  J Am Coll Cardiol: 2004:43:29A.
  27. Gurujal R, Maganti K, Seghatol F, Smulevitz B, Cotts W, Gheorghiade M, Bonow RO, Dove E, Rigolin VH. Morphologic sape changes of the left ventricle following beta blocker therapy in heart failure patients using three dimensional echocardiography: a more pronounced effect in patients with dilated cardiomyopathy with contractile reserve at baseline. J Am Soc Echocardiogr (in press).
  28. Haupt ME, Fieno D, Dibs S, Carr JC, Krupinski E, Fasanati C, Leloudas N, Pereles FS. Rapid determination of cardiac output by a single breath-held aortic flow quantification: correlation with left ventricular contouring technique (abstract). J Cardiovasc Magn Reson 2004; 6 (suppl):443.
  29. Hernandez AF, Gattis WA, Garg J, Chu A, Chandler AB, Gheorghiade M, O'Connor CM. Safety of beta-blockers in patients with heart failure and renal insufficiency: data from IMPACT-HF. J Am Coll Cardiol 2004;43:157A.
  30. Herrmann HC, Wasserman HS, Whitlow PL, Block PC, Gray WA, Foster E, Feldman T.  Percutaneous edge-to-edge mitral valve repair: results of the EVEREST-I study.  Circulation 2004;110:III-439.
  31. Huang SL, McPherson DD, MacDonald RC.  Acoustically active liposomes for olignonucleotide/drug encapsulation: delivery agents with capacity for ultrasound-triggered release. Molecular Ther 2004;9:S183.
  32. Iyer S, Xu Y, Rosenson R, Rajagopalan R.  Lower cardiovascular risk associated with pioglitazone monotherapy compared to insulin monotherapy: a retrospective propensity score matched cohort study. Value in Health 2004;7:220.
  33. Januzzi, JL, Camargo CA Jr, Anwaruddin S, Baggish A, Chen A, Krauser D, Tung R, Nagurney T, Chae C, Lloyd-Jones DM, Brown DF, Sluss PM, Lewandrowski EL, Lewandrowski KB. N-Terminal pro-brain natriuretic peptide (proBNP) measurement for the emergency diagnosis of congestive heart failure: The ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2004;43:235A.
  34. LaBresh KA, Smith SC Jr, Tyler PA, Skea W, Albright D, Bonow RO. Does Get With the Guidelines – Coronary Artery Disease reduce treatment disparities among different racial and ethnic groups? Circulation 2004;110:III-801
  35. Lee CR, Patterson JH, Gattis WA, O'Connor CM, Schwartz TA, Gheorghiade M, Adams KF.  Renal function, independent of ejection fraction and heart size, is a predictor of mortality in patients with heart failure and preserved ejection fraction: a retrospective analysis of the Digitalis Investigational Group (DIG) Trial. J Card Fail 2004;10:S87.
  36. Lee DC, Simonetti OP, Wu E, Harris KR, Holly TA, Klocke FJ. Transmural flow gradient measured by magnetic resonance perfusion imaging improves identification of coronary stenoses. Circulation. 2004;110:III-756.
  37. Lee DC, Wu E, Holly TA, Simonetti OP, Harris KR, Bonow RO, Klocke FJ. Enhanced Identification of endocardial to epicardial flow differences by M-Mode display of magnetic resonance first-pass perfusion studies. J Cardiovasc Magn Reson 2004;6 (suppl):370.
  38. Lloyd-Jones DM, Evans JC, Levy D. Epidemiology of hypertension in the old old: data from the community in the 1990s. Am J Hypertens (in press).
  39. Lloyd-Jones DM, Larson MG, Keyes M, Levy D, Clouse ME, O’Donnell CJ. Resting 12-lead electrocardiogram predicts presence and extent of coronary calcification cross-sectionally and prospectively. Circulation 2004;110:III-804.
  40. Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, Lewis CE, Savage P. Consistently stable body mass index and changes in risk factors associated with the metabolic syndrome. Circulation. 2004;110:III-772.
  41. Maganti K, Di Rosa S, Goldberger J, Rigolin VH. Flow velocities in the left atrial appendage are variable depending on the plane and site of measurement.  J Am Soc Echocardiogr (in press).
  42. Murabito JM, Nam BH, D’Agostino RB, Lloyd-Jones DM, Wang TJ, Wilson PW, O’Donnell CJ. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: the Framingham Offspring Study. Circulation 2004;110:III-764.
  43. Nealis TB, Stock S, Siddiqi S, Thenappan T, Sebo TC, Carmichael SW, Fredericksen J, Subramanium M, Edwards WD, Spelsberg TC, Bonow RO, Rajamannan N. Neoangiogenesis via vascular endothelial growth factor expression is associated with an osteoblast-like bone formation in calcified rheumatic heart valves. J Am Coll Cardiol 2004; 43:433A
  44. Nielsen CD, Ansel G, Sharma R, Fail P, Khan MA, Keller VA, Stoler R, Sanborn TA, Hall P, Hammett C, Caputo R. Angiolink EVS arteriotomy staple mediated closure device: safety and effectiveness in patients undergoing PCI with larger sheaths. Am J Cardiol 2004;94:59E.
  45. O'Connor CM, Adams KF Jr., Gattis WA, Barbagelata A, Elkayam E, Mc Grew F, Ghali J, Benza R, Klapholz M, Ouyang J, Orlandi O, Mihai Gheorghiade. Predictors of mortality in patients hospitalized with worsening heart failure: insights from the ACTIV in CHF Trial. J Am Coll Cardiol 2004;43:181A.
  46. Passman R Anderson KP, Subaclus H, Achaechter A, Howard A, Callkins H, Kadish A. Superior quality of life in patients with non-ischemic dilated cardiomyopathy and implantable cardioverter-defibrillators: results from the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Study. Circulation 2004;110:III-625.
  47. Passman R, Robin J, Weinberg K, Tiongson J, Quadrini M, Ciaccio C, Carnethon M, Gamal A, Kadish A, Goldberger J. Increased risk of appropriate ICD therapy in renal dialysis patients. Heart Rhythm Heart Rhythm 2004;1:S33.
  48. Patterson JH, Lee CR, Gheorghiade M, Gattis WA, O'Connor CM, Schwartz TA, Adams KF Jr. Clinical severity predicts response to digoxin: a retrospective analysis of the Digitalis Investigational Group (DIG) Trial. J Card Fail 2004;10:S87.
  49. Quadrini M, Ciaccio C, Weinberg K, Robin J,  Tiongson J, Gamal A, Passman R.  Mortality in post-myocardial infarction patients with chronic renal insufficiency: the role of ventricular arrhythmias. Am J Kidney Dis 2004;43:A39.
  50. Racker, DK, Kadish AH.  Modification of AV nodal conduction by photoablation of a single AV nodal input. FASEB J 2004:A278.
  51. Ricciardi MJ, Kim CX, Wu E, Lee DC, Davidson CJ, Bonow RO. Cardiac MRI within one week of coronary stent implantation is safe. Am J Cardiol 2004;94:54E.
  52. Robbins, J, Passman R. Implantable defibrillator therapy and end-stage renal disease. J Am Assoc Nephrol  2004;14:768A.
  53. Rodriguez LL, Acquatella H, Wiegers S, Silvestry F, Zunamon A, Merlino A, Martin R, Krabil K, Foster E, Feldman T, Komtebedde J, Stewart WJ. Percutaneous edge-to-edge repair for mitral regurgitation guided by transesophageal and transthoracic echocardiography.  J Am Coll Cardiol 2004;43:25A.
  54. Rosenson RS.  Risk and benefit of statin therapy. Acta Cardiol Sinica 2004;20(Suppl I):89.
  55. Rosenson RS, Huskin A, Wolff D.  Combined therapy with dipyridamole and aspirin reduces blood viscosity at low shear rates: An important antithrombotic property. Stroke 2004; 35:303.
  56. Rosenson RS, Huskin A.  Postprandial lipoproteinemia exhibits a bimodal response in metabolic syndrome patients. J Am Coll Cardiol 2004;34:464A.
  57. Russo RJ, Wong SC, Marchant D, Attubato MJ, Korr K, Davidson CJ, Tuczu MJ, Feldman T, Ling FS, Silva PD: Intravascular ultrasound is superior to angiography for assessment of a left main angiographic stenosis of less than 50% to determine the need for revascularization: observations from the Left Main IVUS Registry. Circulation 2004;110:III-525.
  58. Saleem M, Burkett S, Passman R, Dibs S, Engelstein E, Kadish A, Goldberger J. New simplified technique for 3-D mapping and ablation of right ventricular outflow tachycardia.  J Am Coll  Cardiol  2004;43:138A.
  59. Schwartz G, Olsson A, Chaitman B, Goldberger J, Szarek M, Sasiela, W: Effect of intensive statin treatment on the occurrence of atrial fibrillation after acute coronary syndrome:  an analysis of the MIRACL trial.  Circulation 2004;110: III-740.
  60. Sheldon WS, O’Shaughnessey CD, Popma JJ, Ellis SE, Stone GW, Williams DO, Davidson CJ, Brown CL, Russel M. Clinical and angiographic reduction in restenosis in longer drug-eluting stents compared with bare metal stents from the TAXUS IV Trial. Am J Cardiol 2004;94:220E.
  61. Sheldon WS, Popma JJ, Brown, CL, Davidson CJ, Williams DO, O’Shaughnessey CO.  Clinical and angiographic restenosis rates as a function of drug-eluting and bare metal implanted stent length: analysis from the TAXUS IV Trial. Circulation 2004;110:III-734.
  62. Stone P, Lloyd-Jones DM, Johnstone M, Carlson W, Rubenstein J, Creager M, Frei B, Sopko G, MacCallum G, Cole H, Kinlay S, Orav J, Selwyn A. The effect of intensive lipid-lowering, with or without antioxidant vitamins, versus moderate lipid-lowering on ambulatory and exercise-induced ischemia in patients with stable coronary disease: The Vascular Basis for the Treatment of Myocardial Ischemia Study. J Am Coll Cardiol 2004;43 (5 suppl A):Late Breaking Clinical Trials
  63. Sundaram S, Shoushtari C, Carnethon M, Kadish A, Goldberger J. Autonomic and non-autonomic determinants of heart rate recovery. Heart Rhythm 2004;1:S100-S101.
  64. Taneja T, Monaco L, Schmittdiel J, Passman R, Arora R, Dibs S, Engelstein E, Kadish A, Goldberger J. Provoked high frequency noise transients in patients with implantable cardioverter defibrillators (ICD). Heart Rhythm, 2004;1:S210.
  65. Taneja T, Passman R, Goldberger J, Kadish A. Differences in the rate of implantable cardioverter defibrillator (ICD) discharge between patients receiving ICD’s for primary vs. secondary prevention of SCD. Heart Rhythm, 2004;1:S114.
  66. Tiongson J, Weinberg K, Robin J, Passman R: Fast ventricular tachycardia induced by programmed stimulation predicts appropriate implantable cardioverter defibrillator therapy. Circulation 2004;110:III-504.
  67. Tiukinhoy SD, Huang SL, Maganti K, MacDonald RC, McPherson DD.  Novel echogenic tissue plasminogen activator-loaded liposomes for site-specific thrombolysis.  Circulation 2004;110: III-509-510.
  68. Ulphani J, Winghagen-Mahnert, Aggerwal R, Johnson D, Racker D, Gordon D, Taneja T, Goldberger J, Kadish A.  Mode and site of induction affects the organization of atrial fibrillation in the canine atrium. J Am Coll Cardiol 2004;43:378A.
  69. Vidovich M, Lee DC, Wu E, Myers BD, Dravid RR, Davidson CJ. Effects of magnetic resonance imaging and balloon inflation on stability of drug-eluting stent polymer: an in-vitro study. Am J Cardiol 2004;94:157E.
  70. Wen KC, Sanborn TA, Sherman W, Brown DL. Effect of obesity on long-term survival following percutaneous coronary intervention. J Am Coll Cardiol 2004;43:410A.
  71. Wu E, Lee DC, Simonetti O, Chung YC, Klocke FJ, Beohar N, Bonow RO, Holly TA. Rapid, accurate detection of myocardial infarcts using phase-sensitive inversion–recovery: comparison to standard IR-Flash methods. J Cardiovasc Magn Reson 2004;6:438.
  72. Wu E, Lee DC, Holly TA, Choudhury L, Meyers SN, Pereles FS, Klocke FJ, Bonow RO. Ventricular remodeling following acute ST-segment elevation myocardial infarction in patients undergoing primary angioplasty. J Cardiovasc Magn Reson 2004:6;160.
  73. Wu E, Tejedor P, Lee DC, Holly TA, Carr JC, Klocke FJ, Bonow RO. No reflow detected by delayed contrast enhancement predicts ventricular remodeling following an ST-segment elevation myocardial infarction. Circulation. 2004;110:III-444.
  74. Xi E, Sahakian AV, Hg J, Swiryn S. Atrial fibrillatory wave characteristics on surface electrogram: ECG to ECG repeatability over twenty-four hours in clinically stable patients. J Cardiovasc Electrophysiol 2004;15:911-917.
  75. Yakubov S, Sharma R, Fail P, Khan MA, Keller VA, Stoler R, Nielsen C, Sanborn TA, Hall P, Hammett C, Caputo R, Ansel GM. Angiolink EVS arteriotomy staple-mediated closure device: safety and effectiveness  in percutaneous coronary intervention. Am J Cardiol 2004;94:201E.
  76. Zannad F, Gheorghiade M, Krum H, Chu TC, Patni R, Pitt B. The effect of eplerenone on all-cause mortality and heart failure hospitalization in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). J Card Fail. 2004;10:S76.

CD-Roms

In: Rose B, ed. UpToDate.  BDR, Inc., Wellesley, MA 02181.  2004; Vol. 12.1

  1. Rosenson RS.  Approach to the patient with hyper-triglyceridemia 
  2. Rosenson RS, Reeder GS, Kennedy HL.  Beta blockers in acute myocardial infarction 
  3. Rosenson RS, Reeder GS, Kennedy HL.  Clinical trials of cholesterol lowering for primary prevention of coronary heart disease 
  4. Rosenson RS.  Lipid lowering with fibric acid derivatives 
  5. Rosenson RS.  Screening guidelines for dyslipidemia 
  6. Rosenson RS.  Lp(a) metabolism and approach to the patient with high Lp(a) levels
  7. Rosenson RS, DK McCulloch.  Treatment of dyslipidemia in diabetes mellitus 
  8. Rosenson RS.  Treatment of dyslipidemias in the elderly 
  9. Rosenson RS, Tangney CC.  Cardiovascular benefits and risks of moderate alcohol consumption 
  10. Rosenson RS.  Cholesterol-lowering after an acute coronary syndrome 

In: Rose B, ed. UpToDate.  BDR, Inc., Wellesley, MA 02181.  2004; Vol. 12.2

  1. Rosenson RS.  Clinical trials of cholesterol lowering in patients with coronary heart disease 
  2. Rodriguez O, Braun LT, Rosenson RS.  Components of cardiac rehabilitation and exercise prescription 
  3. Martin KA, Rosen HN, Rosenson RS.  Estrogen replacement therapy and cardiovascular risk 
  4. Braun LT, Rosenson RS.  Exercise assessment and measurement of exercise capacity in patients with coronary heart disease
  5. Rosenson RS.  HDL metabolism and approach to the patient with low HDL-cholesterol 
  6. Tangney CC, Rosenson RS.  Lipid lowering with diet or dietary supplements 
  7. Rosenson RS.  Lipid lowering with drugs other than statins and fibrates 
  8. Rosenson RS.  Lipid lowering with HMG CoA reductase inhibitors (statins) 
  9. Rosenson RS.  Lipoprotein classification; metabolism; and role in atherosclerosis 
  10. Rosenson RS.  Measurement of serum lipoproteins 
  11. Rosenson RS, Kang DS.  Overview of homocysteine
  12. Reeder GS, Kennedy HL, Rosenson RS.  Overview of the management of acute ST elevation (Q wave) myocardial infarction 
  13. Rosenson RS.  Overview of treatment of hypercholesterolemia 
  14. Rosenson RS.  Primary disorders of LDL-cholesterol metabolism
  15. Rosenson RS.  Treatment of drug-resistant hypercholes-terolemia 
  16. Rosenson RS, DK McCulloch.  Treatment of dyslipidemia in diabetes mellitus
  17. Rosenson RS. Treatment of dyslipidemias in the elderly.
  18. Rosenson RS.  Patient information: hyperlipidemia

In: Rose B, ed. UpToDate.  BDR, Inc., Wellesley, MA 02181.  2004; Vol. 12.3

  1. Rosenson RS.  Muscle injury associated with lipid lowering drugs